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Abstract

Introduction

This paper reviews studies performed by this laboratory involving the macrophage response to implant particles. Through the development of a tissue culture
model, we have studied the events which occur following macrophage phagocytosis of bone cement particles,
the released mediators and cell interactions which may
ultimately lead to bone resorption, and the inhibition of
this process with the use of pharmaceutical agents. This
is divided into the following sections: Histologic response of macrophages to cement particles I toxicity I
and mediator release, the effects of particle size and
composition on mediator release by macrophages, macrophage I osteoblast interactions, macrophage I osteoblast I osteoclast interactions, the role of tumor necrosis
factor alpha in particulate induced bone resorption,
mechanisms of cellular recruitment in aseptic loosening,
macrophage I osteoblast coculture model, titanium, pharmaceutical inhibition of particulate induced bone resorption, and work by other investigators using the macrophage model.

Aseptic loosening can be defined as the failure of
the bond between implant and bone in the absence of
infection. Most investigators currently believe that
aseptic loosening is secondary to bone resorption at the
interface between implant and bone stimulated by the
presence of particulate wear.
When we began working on this project in 1983,
very little interest centered on the possible role of particulates in aseptic loosening with most theories involving some type of toxic response to the polymethylmethacrlyate cement (PMMA). Petty [21] had demonstrated
the toxic effects of polymethylmethacrylate monomer
upon leukocytes. Stauffer [23] suggested that loosening
may be a result of bone necrosis at the bone-cement interface secondary to exothermia of polymerization of the
cement, or from the physical presence of cement in the
bone interstices. Linder and Romanus [19] suggested
that resorption at the interface may be secondary to bone
necrosis resulting from an impairment of bone vasculature. Pederson [20] demonstrated an inhibitory effect of
PMMA monomer upon bone turnover in vitro and suggested that monomer may play a role in loosening by inhibiting bone formation at the interface. These theories
became less popular when retrieval studies of well fixed
implants from cadavers demonstrated little if any evidence of necrotic bone. In addition, further studies on
the kinetics of polymethylmethacrylate monomer dissolution demonstrated that within a few hours to at most a
few days, no monomer could be detected at the site of
polymerization even by the most sensitive methods.
Aseptic loosening usually takes several years to occur,
and so, it is unlikely that any detectable monomer is
present when the interface is converting from a wellfixed to loose histologic appearance.
The early in vitro models of the loosening process
primarily involved exposing cells to polymethylmethacrylate monomer in tissue culture and then studying the
degree to which this monomer was toxic. This evolved
from the initial theories in which it was believed that a
toxic response to implantation of the PMMA was a
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not occur when the cells were exposed to the same
concentration of polystyrene particles. Exposure to both
PMMA and polystyrene particles led to release of
arachidonic acid metabolites. These studies demonstrated the coexistence of both the toxic and stimulatory
effects upon macrophage physiology of PMMA particle
phagocytosis [12, 13].

major factor in later loosening.
In the late 1970's and early 1980's, a clearer picture
of the loose and well fixed bone cement interfaces were
emerging from the retrieval studies. Willert [24] demonstrated a relationship between the presence of small
prosthetic particles and what he described as a foreignbody reaction which included a macrophage response in
the tissue which surrounds prosthetic joints. This was
followed by histologic studies demonstrating an association between macrophage phagocytosis of particles and
bone resorption at the loose interface, which led to the
theory that the mechanism of loosening may not be a
toxic response to cement implantation, but instead an inflammatory response to the production of particulates [2,
3]. The most widely accepted theory at the present
time, is that the release of mediators from macrophages
engaged in particle phagocytosis stimulates bone-resorption at the bone/implant interface. It is this resorption
which disrupts the bond formed between implant and
bone and ultimately leads to clinically recognized
loosening.
The basis of the in vitro model for aseptic loosening
which we have been developing, is to more clearly understand the mechanism of this process by bringing the
material (particulate) and cellular elements of the interface together in a controlled environment and studying
the response.

Effects of particle size and composition upon
mediator release by macrophages
In our next study, we demonstrated that macrophages which phagocytized particles of cement in tissue
culture were similar morphologically to macrophages
which phagocytized cement particles at the interface in
vivo. This response occurred with cement preparations
actually used in the operating room, and there was no
difference between commercially available bone cement
preparations such as Simplex (Howmedica; Rutherford,
New Jersey) or Palacos (Richards; Zimmer, Warsaw,
Indiana). Phagocytosis of the particles appeared to be
an essential component of the response. The release of
mediators was a specific response with the major mediator released being tumor necrosis factor alpha (TNF -a)
[15].
On the basis of these studies, we proposed that the
mechanism of aseptic loosening was a macrophage-mediated response with two components. The first involves
recognition of the mechanical failure of the cement
mantle, which results from the production of particles
small enough too be phagocytized by macrophages (less
than fifteen micrometers). This initiates a biologic
response that is characterized by a repetitive cycle of
particle phagocytosis and cell death with release of
certain bone resorbing mediators, one of which is tumor
necrosis factor but not prostaglandin E2 (PGE 2) [ 15].

Research on Macrophage Response to
Implant Particles
Histologic response of macrophages to cement
particles I toxicity and mediator release
In our first project, we were interested in whether
macrophages would phagocytize PMMA particles in
vitro as they were appearing to do at the interface in the
retrieval studies, and also whether phagocytosis of these
particles was toxic to these cells. This interest in toxicity arose from prior studies demonstrating the toxicity of
the monomer. In our first experiment, rat peritoneal
macrophages were exposed to PMMA particles obtained
by grinding a block of cement with a drill bit. This
simple experiment demonstrated active phagocytosis of
these particles by macrophages. In addition, many cells
detached from the bottom of the plates and electron
microscopy demonstrated these to be dying or dead with
PMMA particles within phagosomes.
In the studies which followed, it was demonstrated
that exposure to PMMA particles significantly inhibited
DNA synthesis and cytotoxic function, and also led to
lactate dehydrogenase release reflecting cell injury [12,
13]. This response was not secondary to any soluble
contaminants such as monomer, nor was it simply a dose
response to the physical presence of particles since it did

Macrophage I osteoblast interactions
The previous experiment demonstrated that exposure
of macrophages to PMMA particles leads to release of
specific mediators one of which is TNF-a, but not
PGE 2. PGE 2 is an inflammatory bone resorbing
mediator which has been implicated in several studies as
being associated with the loosening process [14].
In addition to macrophages, there are other cells
present at the interface in aseptic loosening which are
capable of PGE 2 production such as osteoblasts. In this
study, osteoblasts which were incubated in conditioned
medium from macrophages exposed to cement particles
small enough to be phagocytized, increased PGE 2 release eighty fold over unexposed osteoblasts. Incubation
of osteoblasts in conditioned medium from macrophages
exposed to particles too large to be phagocytized, or to
bone cement filtrate, did not lead to PGE 2 release.
Based on this, we hypothesized that PGE 2 release in
aseptic loosening may be originating from osteoblasts in
184
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Role of tumor necrosis factor alpha in particulate
induced bone resorption

response to mediators (such as TNF -a) produced by
macrophages following PMMA particle phagocytosis,
rather than directly from macrophages [16].

The prior studies have demonstrated the production
of tumor necrosis factor alpha (TNF-a) as the most consistent mediator release following PMMA particle exposure. This fmding suggests that TNF-a plays a role in
particulate induced bone resorption but does not demonstrate a cause and effect relationship. The purpose of
this study was to determine the role of TNF-a in bone
resorption secondary to mediator release from macrophages exposed to cement particles. Macrophage exposure to PMMA particles over a time course from 30
minutes to 96 hours led to an increase in TNF -a which
was initially detected at 30 minutes with a maximum at
48 hours. Incubation with the macrophage I PMMA
conditioned medium significantly increased 45 Ca release
and PGE 2 release by calvaria. To study the role of
TNF -a release in bone resorption, the macrophage I
PMMA conditioned medium was then pre-incubated with
anti-TNF-a antibody prior to exposure to the conditioned
medium to the calvaria. This pre-incubation was successful in significantly inhibiting 45 Ca release by calvaria
(p < 0.01), to levels which were not significantly different from unexposed calvaria [1].
This study demonstrates that TNF-a plays a critical
role in initiating particulate induced bone resorption.
The sequence of events in this model for particulate induced bone resorption appears to be initiated by the production of TNF -a by the macrophage, followed by production of PGE 2 by bone cells which then induces bone
resorption.

Macrophage I osteoblast I osteoclast interactions
The hypothesis derived from the prior studies is that
the mechanism of aseptic loosening involves a macrophage I osteoblast I osteoclast process as opposed to a
direct macrophage I osteoclast interaction. To test this
hypothesis, we exposed isolated osteoclasts to conditioned medium from macrophages incubated with particles, with and without an osteoblast contribution.
Incubation of osteoclast precursors in the presence of
macrophage I PMMA medium with an osteoblast contribution, increased the number of rat osteoclast precursors
which migrated on to a calcified substrate (dentin). In
contrast, incubation of the osteoclast precursors with
macrophage I PMMA medium without the osteoblast
contribution, not only did not stimulate migration to he
dentin slice but actually resulted in a decrease in the
number of osteoclasts compared to unexposed control.
This study supports the hypothesis that osteoblasts
play an important role in macrophage I PMMA osteoclastic bone resorption [22].

Mediator interactions in particulate induced bone
resorption
The purpose of this study was to determine whether
or not particulate induced bone resorption was occurring
by a mechanism which was dependent upon PGE 2 production by cells in bone. Macrophages were exposed to
cement particles, and then this conditioned medium was
exposed to rat calvarial bones in vitro. The macrophage
conditioned medium contained increased levels of tumor
necrosis factor alpha (TNF-a), but not interleukin 1
(IL-l) or PGE 2. Exposure of this medium to the calvaria led to release of PGE 2 by the calvaria, but not
TNF-a or IL-l. At 24, 48, 72, and 96 hours of incubation, the macrophage I cement particle conditioned mediurn led to the release of both PGE 2 and 45 Ca (bone resorption) from the calvaria. To determine if the release
of 45ca was dependent upon PGE 2 production by the
cells in bone, the calvaria were incubated with 600
nglml of indomethacin (Sigma Chemicals, St. Louis,
Missouri) in addition to the macrophage conditioned
medium. The addition of indomethacin was effective in
inhibiting both PGE 2 and 45 Ca release from calvaria,
even after 96 hours of exposure to the macrophage
conditioned medium [10].
This study demonstrates that macrophage exposure
to bone cement particles leads to the release of mediators
which stimulate bone resorption at least in part, through
a prostaglandin E2 dependent mechanism.

MechanisnlS of cellular recruitment

in aseptic

loosening
One of the features which differentiates the well
fixed from the loose interface, is the influx of macrophages, fibroblasts and osteoclasts. These cells are
present in only small numbers in the well fixed interface, but are present in large numbers in the aseptically
loose interface. Many investigators have speculated that
the recruitment of these cells is an essential component
of the loosening process. The purpose of this study was
to improve our understanding of the mechanism by
which recruitment of these cells into the interface
occurs.
TNF -a is known to be capable of stimulating the release of granulocyte macrophage colony stimulating factor (GM -CSF) and interleukin 6 (IL-6) from osteoblasts.
Both of these mediators have been demonstrated to be
capable of stimulating recruitment of cells such as macrophages, fibroblasts and osteoclasts, into sites of inflammation [9]. The prior studies have demonstrated
that TNF -a is consistently released following exposure
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of macrophages to PMMA particles, and that this mediator plays an important role in PMMA particulate stimulated bone resorption. In this study, it was demonstrated
that incubation of osteoblasts with conditioned medium
from macrophages exposed to PMMA particles leads to
the release of GM-CSF, IL-6, and PGE 2. In addition,
incubation of the macrophage I particle conditioned
medium with antibodies to TNF -a prior to osteoblast
exposure inhibited release of GM-CSF, IL-6, and
PGE 2. This demonstrates that exposure of macrophages to PMMA particles leads to release of TNF -a
which then stimulates osteoblasts to produce GM -CSF,
IL-6, and PGE 2. This supports a role for TNF-a not
only in particulate induced bone resorption at the interface, but also in stimulating the release of secondary
mediators from surrounding cells which leads to the
recruitment of other cells into the interface that play a
role in the loosening process [ 11].

IL-l . Osteoblasts increased production of PGE 2 when
exposed to media from titanium-stimulated macrophages
but not IL-6 or granulocyte macrophage-colony stimulating factor. Media from macrophages exposed to titanium did not lead to bone resorption, as measured by 45 ea
release in organ culture. This result is different from
the prior studies in which calvaria exposed to media
obtained following exposure of macrophages to titanium
which were in coculture with osteoblasts, did lead to
45
Ca release. The cellular response to titanium is characterized by release of TNF -a from macrophages, and
PGE 2 from osteoblasts exposed to the macrophage conditioned medium. A comparison of the results of this
study with others involving exposure of macrophages in
tissue culture suggests that titanium may not be as inflammatory as other particles in the aseptically loose
joint [5].
Phannaceutical inhibition of particulate induced bone
resorption

Macrophage I osteoblast coculture model
At the interface of the loose prosthesis, macrophages, osteoblasts and fibroblasts are all in close
proximity. The prior studies evaluated the effects of
mediator released from macrophages upon osteoblasts,
but did not take into account the potential effects of
mediators released from osteoblasts, or other cells
present in bone, upon macrophages.
The purpose of this study was to further defme the
cellular response to titanium (pure) and PMMA particles
in aseptic loosening in a more physiologic environment
where macrophages and osteoblasts are cultured together. Macrophages and osteoblasts were cocultured to
stimulate the environment around an aseptically loose
prosthesis. Macrophages were plated on the bottom of
six well plates while osteoblasts were plated on culture
dish inserts, and placed into the wells with the macrophages. Incubation of macrophages with PMMA in this
system led to release of PGE 2, GM -CSF and IL-6. Incubation with titanium led to release of tumor necrosis
factor alpha and IL-6. Exposure of calvaria to media
from cells exposed to either PMMA or titanium, led to
release of 45 Ca [8].
This study is consistent with prior results demonstrating release of TNF-a. It also revealed release of
other mediators previously identified as playing a role in
this process, as well as the stimulation of bone resorption.

Pharmacologic inhibition of the pathway leading to
bone resorption offers the potential for improving implant longevity. In this study, a rat calvaria I macrophage coculture model was used to study the effects of
various agents upon bone resorption induced by macrophage exposure to bone cement particles. The experimental group consisted of calvaria bone disks set in tissue culture medium on stainless steel platforms into
wells with macrophages adherent to the bottom which
are exposed to the particles. This was compared to the
opposite (control) side calvaria in which the wells did
not contain macrophages. The medium from this system
was first assayed to 45 Ca, TNF-a, interleukin 1-alpha
(IL-la), and PGE 2 release. The system was then challenged with indomethacin, anti-TNF antibody, calcitonin
(Rorer Pharmaceuticals, Fort Washington, PA) and pamidronate (Ciba Pharmaceuticals, Summit, NJ).
TNF-a, PGE 2, and 45 Ca were released in significant amounts in this system when compared to control.
IL-la was not detected in this system. Indomethacin inhibited the production of PGE 2, but did not affect
TNF-a release or inhibit release of 45 Ca. Anti-TNF
antibody neutralized the presence of TNF-a to undetectable levels, but did not affect PGE 2 release or inhibit
45 Ca release. Addition of calcitonin did not inhibit 45 Ca
release by calvaria. In contrast, addition of pamidronate
was effective in inhibiting release of 45 Ca even after 96
hours of incubation.
In the prior studies using the same cell line and
particle preparation but with a "one-way" model, bone
resorption stimulated by incubating calvaria with media
obtained from macrophages exposed to particles was dependent upon TNF-a and PGE 2 release. In the "twoway" model, in which macrophages are incubated with

Titanium
The purpose of this study was to defme the role
which titanium debris plays in aseptic loosening. Macrophages exposed to commercially pure titanium (1-3
micrometer) exhibited a mediator profile similar to those
exposed to polymethylmethacrylate. This response consisted of increased release of TNF -a but not PGE 2 or
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particles in the same well as the calvaria, this relationship no longer exists. In this system, pamidronate
was the only agent tested which suppressed the increase
in bone resorption associated with the macrophage exposure to bone cement particles to levels which were not
significantly different than unexposed calvaria. This
suggests that agents which act late in the pathway leading to bone resorption may be more effective than those
which work by inhibiting a particular mediator earlier in
the pathway [17].
The findings from this study demonstrate that pamidronate, or other bisphosphonates, may be effective in
inhibiting bone resorption at the implant I bone interface
in association with the macrophage response to implant
particulates.

inflammatory mediators one of which is TNF-a. The
particles are ultimately toxic to the macrophage as
reflected by inhibition of DNA synthesis, inhibition of
cytotoxic function and release of lactate dehydrogenase.
Ultimately the cell dies with release of the particles for
phagocytosis by another macrophage. The TNF -a
which is released by the macrophage stimulates osteoblasts to produce granulocyte macrophage colony stimulating factor and IL-6, both of which stimulate recruitment of additional macrophages, osteoclasts, and other
inflammatory cells into the area of particle accumulation
at the interface. TNF -a also stimulates PGE 2 release
by the osteoblasts which may have an effect on down
regulating further production of TNF -a and also in stimulating osteoclastic bone resorption. This bone resorption disrupts the bond formed between implant and bone,
and leads to clinically recognized aseptic loosening.
The demonstration that the bone resorption stimulated by macrophage exposure to these particles can be
inhibited by a bisphosphonate, offers the hope that these
agents may one day play a role clinically in treating patients who have aseptic loosening of their prosthetic reconstructions.

Work by Other Investigators
In general, our studies are in agreement with other
investigators as they have also concluded that release of
cytokines is a crucial component in the mechanism of
aseptic loosening. One area of difference in our results
relates to the production of interleukin 1-beta (IL-18).
Other investigators have found IL-18 release following
particle exposure in greater amount than were detected
in our studies [6]. These differences may be secondary
to use of different cell lines, conditions of exposure, or
particle preparations. In our experiments, we have only
found small amounts of this mediator produced, with
TNF -a being by far the mediator released most consistently, in greatest amounts, and upon which the response
of osteoblasts, and bone resorption is most dependent.
The work in our laboratory has primarily focused on
the role of macrophages I osteoblasts I and osteoclasts in
the mechanism of aseptic loosening. Work by other investigators have attempted to determine if other cell
types such as lymphocytes are involved, and if there is
evidence of an immunologic type response. These investigations have involved examining the interface from
loose prostheses for lymphocytes, as well as implanting
particles into animals with and without immunologic deficiencies and studying the immunologic response. Although there is some controversy, most of the studies indicate that the role of lymphocytes in aseptic loosening
is minimal [4, 7, 18].
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Discussion with Reviewers

J .L. Saffar: Why do some macrophages die after phagocytosis of PMMA particles? Does macrophage death
contribute to the clinical and in-vitro features, for instance by releasing mediators stored in the cells, e.g.,
proteolytic enzymes?
Author: This question raises several interesting points.
We have found PMMA particles to be toxic to macrophages as reflected by several parameters including release of intracellular LDH (lactate dehydrogenase) and
inhibition of DNA synthesis [12, 13]. These changes
were not seen when macrophages were exposed to
styrene particles when the effects of particle size,
number and shape were controlled for. What the
mechanism is by which PMMA induces its' toxic effect
is unclear but would make an interesting study.
Macrophage death probably contributes to the clinical picture of loosening by releasing particles which can
then stimulate other macrophages to produce inflammatory mediators. In this way, a small amount of particles
can induce a prolonged response. The mediators which
we have studied appear to be synthesized by the cell in
response to particle exposure. This can be seen by increases in the amount of mRNA for TNF-a which is
produced within the cell, in response to particle exposure. We have not studied proteolytic enzymes.

J .L. Saffar:

How can the author explain the discrepancy in mediator release after PMMA or titanium exposure? In particular, why, and how osteoblasts exposed
to medium containing large amounts of TNF -a respond
differently depending on the activating particle? This
strongly suggests that macrophages have released simultaneously other mediators modulating the osteoblast response. Has the author explored this possibility?
Author: It is unclear to us exactly why there is a
difference in mediator release between PMMA and titanium exposure. In general, why some materials tend to
be more inflammatory than others is an interesting and
important question. We speculate that it may relate to
differences in the toxicity of the materials, and the effects of this toxicity upon the synthesis of the inflammatory mediators stimulated by these particles. We are
currently exploring this question.
The difference in the osteoblast response to conditioned medium from macrophages exposed to PMMA
and titanium is probably related to the amount of cytokines in the media. The mediator profile between these
two materials when exposed to the J77 4 macrophage cell
line was the same for all the mediators we tested, but
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studies have demonstrated expression of RNA for IL-1oc
and IL-18, as well as TNF-a in macrophages at the
interface. I am not aware of any studies demonstrating
production of TNF-a or IL-1oc or IL-18 by cell types
other than macrophages at the interface. TNF -a probably does stimulate migration of other cells into the
implant site, but probably through a second mediator
such as GM -CSF or IL-6 [ 11].

there were some differences in the amounts as has been
pointed out. We have found small amounts of IL-18
which may be acting synergistically to enhance the effect
of the TNF-a in the media taken from macrophages exposed to both PMMA or titanium. There is a possibility
that some mediators which we have not assayed for may
also be playing a role. Since the osteoblast response
was inhibited by treatment with antibodies to TNF-a, it
would be our opinion that these mediators are probably
working more to enhance the effects of TNF -a rather
than by stimulating the osteoblasts directly.

N.P. Ziats: Are cell adhesion molecules upregulated in
cells isolated from patients with implants?

Author: We know of no studies which have examined
N.P. Ziats: The role of inflammatory cytokines are important with regards to biocompatibility. Dr. Horowitz's
group has implicated TNF-a as an important mediator
but Giant and co-workers (Giant and Jacobs [6]; Shanbhag et al. [26]), as well as those studying inflammatory
processes with dental materials, have shown significant
levels of IL-1oc or IL-18 production. However, as Dr.
Horowitz states, there are differences with regard to cell
types and conditions. Three questions are important.
One, is the heterogeneity of the patient population so
significant that differences seen cannot be attributed to
isolation of cells or assay technique? Is there any evidence that cells from the interface (not peripheral blood
monocytes), i.e., isolated from the aseptic loosening
sites in human or animal implants, produce these factors? Does TNF -a stimulate the migration of other
macrophages or other cells to these implant sites?
Author: Immortalized cells were used in our study, and
was one of the cell types used in the study by Giant and
Jacobs [6]. Isolation techniques would be more important in comparisons involving human monocytes. It has
been our experience (unpublished) that the mediator profiles between the immortalized cells and isolated monocytes are usually similar although there frequently can be
differences in the amounts of mediators being released.
There are some differences between immortalized lines
as well. For example, some cell lines tend to produce
more TNF-a and others tend to produce more IL-18
given the same stimulus.
We have found IL-18 release, but in much lower
levels than TNF-a (unpublished observation). It should
be noted that in the studies by Giant and Jacobs [6],
TNF -a levels were not determined. In their studies,
addition of antibodies to IL-18, to conditioned media
from macrophages exposed to particles, did not significantly inhibit particulate induced bone resorption. This
is in contrast to our studies, where addition of antibodies
to TNF -a to conditioned medium from macrophages exposed to particles, did inhibit particulate induced bone
resorption [1, 6].
Macrophages at the interface are the main cell type
involved in particle phagocytosis. In situ hybridization

cell adhesion molecules in patients with implants.

N.P. Ziats: Is there any evidence for matrix metalloproteinase production by macrophages (or other cell
types) in response to particles in vitro or in vivo?
Author: We have not studied matrix metalloproteinase
activity. Information on this in the setting of aseptic
loosening is minimal although there is some evidence
that this may be playing a role. One reference for this
would be Takagi [27].
H. Plenk: PMMA-bone cement cured during operation
contains at least 3% residual MMA (monomer) which
can then leach out during the whole implantation period,
even more so when the bulk material is separated into
wear particles. Also, the leaching of the starter substance dimethyl paratoluidine has been demonstrated (in
the German literature [25]); this substance is obviously
toxic and was held responsible for adverse tissue reactions. How can the author state that there is no explanation for the obviously toxic effect of P~1MA particles in
vitro and in vivo, and that the cytotoxic response is not
secondary to any soluble contaminants?
Author: In our experiments on particle toxicity [12,
13], we used a "filtrate" control to control for the presence of soluble toxic contaminants. PMMA particles
were suspended in media and then filtered out with a 0.2
micrometer filter. The resulting filtrate was then exposed to the macrophages and its' effects on toxicity
studied as an additional control. We would expect that
any monomer or starter substance present in the media
would also be present in the filtrate [12, 13].
In our experiments [12, 13, 15], we have used
PMMA particles manufactured for use in research,
crushed polymerized cement from various manufacturers, and the prepolymerized powder (prior to being
mixed with the monomer) supplied by the manufacturer
for use in the operating room. All these preparations
have been demonstrated to be toxic.
In our earlier experiments [12, 13], we compared
PMMA and polystyrene particles which were manufactured for use in research. These particles were the same
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size and shape, and were exposed to macrophages at the
same concentrations. It was found that exposure to the
PMMA particles was toxic but that exposure to the polystyrene particles was not. Both particles led to inflammatory mediator release. Exactly why PMMA particles
are toxic but the styrene particles are not is unclear. I
was not aware of any studies which have answered this
question.

Additional References
[25] Bosch P, Harms H, Lintner F (1982) Nachweis
des Katalysatorbestandteiles Dimethylparatoluidin im
Knochenzement, auch nach mehrjahriger Implantation
(Demonstration of the toxic catalyst constituent dimethylparatoluidine in bone cement, even after longterm implantation). Arch Toxicol Sl: 157-166 (in
German).
[26] Shanbhag AS, Jacobs JJ, Black J, Galante JO,
Giant TT (1995) Human monocyte response to particulate biomaterials generated in-vivo and in-vitro. J Orthop
Res 13: 792-801.
[27] Takagi M (1996) Neutral proteinases and their
inhibitors in the loosening of total hip prostheses. Acta
Orthop Scand 67 (Suppl. 271): 3-29.

190

